Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–386.
   PubMed Web of Science ®Google Scholar
• Kriegel S, Myers J, Befort C, et al. ‘Cancer changes everything!’. Exploring the lived experiences of women with metastatic breast cancer. Int J Palliat Nurs. 2014;20:334–342.
   PubMedGoogle Scholar
• Gupta S, Zhang J, Jerusalem G. The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective. Expert Rev Phamacoecon Outcomes Res. 2014;6:929–940.
   Web of Science ®Google Scholar
• Gerber B, Seitz E, Müller H, et al. Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat. 2003;82:29–37.
   PubMed Web of Science ®Google Scholar
• Harding V, Afshar M, Krell J, et al. 'Being there' for women with metastatic breast cancer: a pan-European patient survey. Br J Cancer. 2013;109:1543–1548.
   PubMed Web of Science ®Google Scholar
• Reed E, Simmonds P, Haviland J, et al. Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey. J Pain Symptom Manage. 2012;43:747–758.
   PubMed Web of Science ®Google Scholar
• Cardoso F, Costa A, Norton L, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Ann Oncol. 2014;25:1871–1888.
   PubMed Web of Science ®Google Scholar
• Glück S, von Minckwitz G, Untch M. Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer. Breast. 2013;22:142–149.
   PubMed Web of Science ®Google Scholar
• Jolly T, Williams GR, Jones E, et al. Treatment of metastatic breast cancer in women aged 65 years and older. Womens Health (Lond Engl). 2012;8:455–471.
   PubMedGoogle Scholar
• Irvin W, Jr, Muss HB, Mayer DK. Symptom management in metastatic breast cancer. Oncologist. 2011;16:1203–1214.
   PubMed Web of Science ®Google Scholar
• Sarenmalm EK, Thorén-Jönsson AL, Gaston-Johansson F, et al. Making sense of living under the shadow of death: adjusting to a recurrent breast cancer illness. Qual Health Res. 2009;19:1116–1130.
   PubMed Web of Science ®Google Scholar
• Willis K, Lewis S, Ng F, et al. The experience of living with metastatic breast cancer-a review of the literature. Health Care Women Int. 2014;36:514–542.
   PubMed Web of Science ®Google Scholar
• Vilhauer RP. A qualitative study of the experiences of women with metastatic breast cancer. Palliat Support Care. 2008;6:249–258.
   PubMedGoogle Scholar
• McClelland SI, Holland KJ, Griggs JJ. Vaginal dryness and beyond: the sexual health needs of women diagnosed with metastatic breast cancer. J Sex Res. 2015;52:604–616.
   PubMed Web of Science ®Google Scholar
• Denieffe S, Cowman S, Gooney M. Symptoms, clusters and quality of life prior to surgery for breast cancer. J Clin Nurs. 2014;23:17–18.
   Web of Science ®Google Scholar
• Warren M. Uncertainty, lack of control and emotional functioning in women with metastatic breast cancer: a review and secondary analysis of the literature using the critical appraisal technique. Eur J Cancer Care. 2010;19:564–574.
   PubMed Web of Science ®Google Scholar
• Badr H, Shen MJ. Pain catastrophizing, pain intensity, and dyadic adjustment influence patient and partner depression in metastatic breast cancer. Clin J Pain. 2014;30:923–933.
   PubMed Web of Science ®Google Scholar
• White CB, Smith ML, Abidoye OO, et al. Impacts of toxicity on patient treatment choices for metastatic breast cancer. J Clin Oncol. 2012;30:18.
   Web of Science ®Google Scholar
• Ghislain I, Zikos E, Coens C, et al. Review. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group the Breast Cancer Group EORTC Headquarters. Lancet Oncol. 2016;17:294–304.
   PubMed Web of Science ®Google Scholar
• Hurvitz SA, Lalla D, Crosby RD, et al. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer. Breast Cancer Res Treat. 2013;142:603–609.
   PubMed Web of Science ®Google Scholar
• Faller H, Strahl A, Richard M, et al. Symptoms of depression and anxiety as predictors of physical functioning in breast cancer patients. A prospective study using path analysis. Acta Oncol 2017;56:1677–1681.
   PubMed Web of Science ®Google Scholar
• Grimsbø GH, Finset A, Ruland CM. Left hanging in the air: experiences of living with cancer as expressed through E-mail communications with oncology nurses. Cancer Nurs. 2011;34:107–116.
   PubMed Web of Science ®Google Scholar
• Halkier B. Fokusgrupper [Focus groups]. Roskilde, Denmark: Roskilde University Press; 2003.
   Google Scholar
• Kvale S. Interviews. An introduction to qualitative research interviewing. Thousand Oaks [CA]: Sage; 1996.
   Google Scholar
• Winther JM, Phillips L. Diskursanalyse som teori og metode [Discourse analysis: a theory and methodology]. Roskilde, Denmark: Roskilde University Press; 1999.
   Google Scholar
• Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62:107–115.
   PubMed Web of Science ®Google Scholar
• Smith ML, White CB, Railey E, et al. Examining patient choices for metastatic breast cancer drugs. J Clin Oncol. 2012;30:6053.
   Web of Science ®Google Scholar
• Thompson E, Stanton AL, Bower JE. Situational and dispositional goal adjustment in the context of metastatic cancer. J Pers. 2013;81:441–451.
   PubMed Web of Science ®Google Scholar